190 related articles for article (PubMed ID: 37196541)
1. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
[TBL] [Abstract][Full Text] [Related]
2. Celastrol inhibits chondrosarcoma proliferation, migration and invasion through suppression CIP2A/c-MYC signaling pathway.
Wu J; Ding M; Mao N; Wu Y; Wang C; Yuan J; Miao X; Li J; Shi Z
J Pharmacol Sci; 2017 May; 134(1):22-28. PubMed ID: 28522217
[TBL] [Abstract][Full Text] [Related]
3. Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway.
Pang X; Yi Z; Zhang J; Lu B; Sung B; Qu W; Aggarwal BB; Liu M
Cancer Res; 2010 Mar; 70(5):1951-9. PubMed ID: 20160026
[TBL] [Abstract][Full Text] [Related]
4. Celastrol Inhibits the Proliferation and Induces Apoptosis of Colorectal Cancer Cells via Downregulating NF-κB/COX-2 Signaling Pathways.
Zhang H; Zhao X; Shang F; Sun H; Zheng X; Zhu J
Anticancer Agents Med Chem; 2022; 22(10):1921-1932. PubMed ID: 34732120
[TBL] [Abstract][Full Text] [Related]
5. Celastrol induces apoptosis of gastric cancer cells by miR-21 inhibiting PI3K/Akt-NF-κB signaling pathway.
Sha M; Ye J; Zhang LX; Luan ZY; Chen YB; Huang JX
Pharmacology; 2014; 93(1-2):39-46. PubMed ID: 24434352
[TBL] [Abstract][Full Text] [Related]
6. Celastrol induces vincristine multidrug resistance oral cancer cell apoptosis by targeting JNK1/2 signaling pathway.
Lin FZ; Wang SC; Hsi YT; Lo YS; Lin CC; Chuang YC; Lin SH; Hsieh MJ; Chen MK
Phytomedicine; 2019 Feb; 54():1-8. PubMed ID: 30668359
[TBL] [Abstract][Full Text] [Related]
7. Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells.
Liu X; Zhao P; Wang X; Wang L; Zhu Y; Song Y; Gao W
J Exp Clin Cancer Res; 2019 May; 38(1):184. PubMed ID: 31053160
[TBL] [Abstract][Full Text] [Related]
8. The Protective Role of Celastrol in Renal Ischemia-Reperfusion Injury by Activating Nrf2/HO-1, PI3K/AKT Signaling Pathways, Modulating NF-κb Signaling Pathways, and Inhibiting ERK Phosphorylation.
Younis NS; Ghanim AMH
Cell Biochem Biophys; 2022 Mar; 80(1):191-202. PubMed ID: 35157199
[TBL] [Abstract][Full Text] [Related]
9. Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB.
Dai Y; Desano J; Tang W; Meng X; Meng Y; Burstein E; Lawrence TS; Xu L
PLoS One; 2010 Dec; 5(12):e14153. PubMed ID: 21170316
[TBL] [Abstract][Full Text] [Related]
10. Celastrol induces lipophagy via the LXRα/ABCA1 pathway in clear cell renal cell carcinoma.
Zhang CJ; Zhu N; Long J; Wu HT; Wang YX; Liu BY; Liao DF; Qin L
Acta Pharmacol Sin; 2021 Sep; 42(9):1472-1485. PubMed ID: 33303989
[TBL] [Abstract][Full Text] [Related]
11. Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells.
Chen G; Zhang X; Zhao M; Wang Y; Cheng X; Wang D; Xu Y; Du Z; Yu X
BMC Cancer; 2011 May; 11():170. PubMed ID: 21569548
[TBL] [Abstract][Full Text] [Related]
12. Celastrol inhibits growth and induces apoptotic cell death in melanoma cells via the activation ROS-dependent mitochondrial pathway and the suppression of PI3K/AKT signaling.
Lee JH; Won YS; Park KH; Lee MK; Tachibana H; Yamada K; Seo KI
Apoptosis; 2012 Dec; 17(12):1275-86. PubMed ID: 23065091
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitizing Effect of Celastrol by Inhibiting G2/M Phase Arrest Induced by the c-myc Gene of Human SW1353 Chondrosarcoma Cells: Network and Experimental Analyses.
Qian J; Zhang Z; Han X; Zhu L; Bian Z; Xie T
Biomed Res Int; 2022; 2022():1948657. PubMed ID: 35141331
[TBL] [Abstract][Full Text] [Related]
14. Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways.
Mou H; Zheng Y; Zhao P; Bao H; Fang W; Xu N
Toxicol In Vitro; 2011 Aug; 25(5):1027-32. PubMed ID: 21466843
[TBL] [Abstract][Full Text] [Related]
15. Celastrol Inhibits Migration and Invasion of Triple-Negative Breast Cancer Cells by Suppressing Interleukin-6 via Downregulating Nuclear Factor-κB (NF-κB).
Yan F; Wu Z; Li Z; Liu L
Med Sci Monit; 2020 Sep; 26():e922814. PubMed ID: 32920591
[TBL] [Abstract][Full Text] [Related]
16. Quinone methide tripterine, celastrol, induces apoptosis in human myeloma cells via NF-κB pathway.
Tozawa K; Sagawa M; Kizaki M
Int J Oncol; 2011 Nov; 39(5):1117-22. PubMed ID: 21850367
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effect of celastrol on human triple negative breast cancer: possible involvement of oxidative stress, mitochondrial dysfunction, apoptosis and PI3K/Akt pathways.
Shrivastava S; Jeengar MK; Reddy VS; Reddy GB; Naidu VG
Exp Mol Pathol; 2015 Jun; 98(3):313-27. PubMed ID: 25818165
[TBL] [Abstract][Full Text] [Related]
18. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.
Yang H; Chen D; Cui QC; Yuan X; Dou QP
Cancer Res; 2006 May; 66(9):4758-65. PubMed ID: 16651429
[TBL] [Abstract][Full Text] [Related]
19. Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways.
Kannaiyan R; Manu KA; Chen L; Li F; Rajendran P; Subramaniam A; Lam P; Kumar AP; Sethi G
Apoptosis; 2011 Oct; 16(10):1028-41. PubMed ID: 21786165
[TBL] [Abstract][Full Text] [Related]
20. Celastrol stimulates hypoxia-inducible factor-1 activity in tumor cells by initiating the ROS/Akt/p70S6K signaling pathway and enhancing hypoxia-inducible factor-1α protein synthesis.
Han X; Sun S; Zhao M; Cheng X; Chen G; Lin S; Guan Y; Yu X
PLoS One; 2014; 9(11):e112470. PubMed ID: 25383959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
